Transine Therapeutics
A clinician by training, Alan is a highly experienced individual who has led the development of a gene-based medicine portfolio and has significant experience in large pharma, biotech and academia. Alan brings significant expertise in viral delivery for projects across a range of therapeutic areas. His expertise in medicines development has been recognised with an Honorary Professorship at the University of Birmingham and in 2014 he was elected Fellow of the Royal Society of Biology.
This person is not in the org chart
This person is not in any offices
Transine Therapeutics
Transine Therapeutics is a developer of biotech platform enhancing therapeutics for the treatment of human disease.